Overexpression of miR-196b has been reported in 71 European pediatric AML with MLL gene rearrangements, NPM1 mutations, as well as FLT3-ITD in cytogenetically normal background (Danen-van Oorschot et al., 2012[7]). Here, KMT2A is linked to acute myeloid leukemia.